Search Orphan Drug Designations and Approvals
-
| Generic Name: | Gleolan |
|---|---|
| Date Designated: | 02/15/2024 |
| Orphan Designation: | diagnostic for the management of ovarian, fallopian tube, and primary peritoneal cancer |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
NX Development Corp. 870 Corporate Drive, Suite 403 Lexington, Kentucky 40503 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







